Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study

Research output: Contribution to journalJournal articleResearchpeer-review

  • Iben F Sorgenfrei
  • Kathrine Norrild
  • Per Bo Larsen
  • Jakob Stensballe
  • Østergaard, Doris
  • Martine E Prins
  • Jørgen Viby-Mogensen
Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.
Original languageEnglish
JournalAnesthesiology
Volume104
Issue number4
Pages (from-to)667-74
Number of pages8
ISSN0003-3022
Publication statusPublished - 1 Apr 2006

ID: 40206002